This webinar will present an overview of the regulation of in vitro diagnostic (IVD) devices in the United States, European Union and Canada. With a primary focus on IVD regulation by the US FDA, the webinar will cover the classification of IVD devices, an overview of data required for different submission types, and special topics. The webinar will also cover the changes in regulatory oversight in the European Union, and will briefly touch on the regulation of devices in Canada, including recent changes related to oversight of the quality system in that country.
Small companies typically are unable to hire the necessary regulatory and quality staff to adequately understand the regulations in the US, EU and Canada and to have productive interactions with regulators. Typically, these companies hire consultants to educate them on these regulations. For a small fee, the attendee of this webinar can obtain a broad overview of the IVD regulations in these three markets and bring back these concepts to their company.
The regulations governing the marketing of in vitro diagnostic devices (IVD) in the United States, European Union, and Canada are complex and in constant flux. This webinar will provide the attendees with a broad overview of how IVD devices are classified and reviewed by the US FDA. The user will also understand how devices are classified in the EU and Canada, and understand the impact of changes to EU regulations. This webinar will be especially useful for leaders of emerging firms who are interested in developing and marketing IVD products in these markets.Areas Covered in the Webinar:
From In Vitro Diagnostic Device Manufacturers
Director of Quality Assurance and Regulatory Affairs, ASELL LLC
Joshua D. Levin, Ph.D., RAC is a regulatory affairs and quality systems expert who has worked for a number of companies in the in vitro diagnostics (IVD) space (ASELL LLC, Personal Genome Diagnostics, and Digene) as well as research products companies (Life Technologies, KPL). In between his stints in industry, Dr. Levin was a reviewer and postmarket team lead at FDA/CDRH with a primary focus on immunology, hematology, and molecular diagnostic products. Dr. Levin is also involved in freelance regulatory/quality consulting work and in educational projects through AAMI and ComplianceOnline.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. FDATrainingAlert would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange.
Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time.
If you have any concern about the content of the webinar and not satisfied please contact us at below email or by call mentioning your feedback for resolution of the matter.
We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email firstname.lastname@example.org call +1-888-771-6965 (Toll Free).
This product hasn't received any reviews yet. Be the first to review this product! Write review